Autolus Therapeutics (AUTL) Other financing activities (2018 - 2024)

Autolus Therapeutics (AUTL) has 7 years of Other financing activities data on file, last reported at $1.8 million in Q2 2024.

• For the quarter ending Q2 2024, Other financing activities rose 740.18% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2025 stood at $1.8 million (down 93.37% YoY), and the FY2024 full-year result was $29.4 million, up 3126.37% from the prior year.
• Other financing activities for Q2 2024 stood at $1.8 million, down from $27.5 million in the prior quarter.
• Across five years, Other financing activities topped out at $27.5 million in Q1 2024 and bottomed at -$7.6 million in Q1 2021.
• The 5-year median for Other financing activities is $512500.0 (2020), against an average of $4.3 million.
• The widest annual swing landed in 2021, when Other financing activities plunged 2367.37%; it then surged 4218.75% in 2023.
• A 5-year view of Other financing activities shows it stood at -$334000.0 in 2020, then soared by 3529.04% to $11.5 million in 2021, then decreased by 9.67% to $10.3 million in 2022, then slumped by 97.88% to $219000.0 in 2023, then jumped by 740.18% to $1.8 million in 2024.
• The last three Other financing activities figures came in at $1.8 million (Q2 2024), $27.5 million (Q1 2024), and $219000.0 (Q2 2023), per Business Quant data.

Peer Comparison